SCHEMBL4068460

SCHEMBL4068460

CNCc1ccccc1Sc1c(C)oc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IFNAR1 P17181 1/20 0.54
▸ RECQL P46063 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SLC6A4 P31645 6/20 0.44
▸ SLC6A2 P23975 5/20 0.44
▸ SLC6A3 Q01959 4/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CA2 P00918 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ G6PD P11413 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CCR6 P51684 1/20 0.38
▸ MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068784 0.74 IFNAR1 (0.60) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
Hydrochloric Acid SCHEMBL4067559 0.73 IFNAR1 (0.58) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
SCHEMBL1399207 0.72 IFNAR1 (0.54) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
SCHEMBL4069373 0.72 IFNAR1 (0.54) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
SCHEMBL11630699 0.71 IFNAR1 (0.68) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
SCHEMBL1253476 0.71 CA2 (0.62) SMN1; SMN2LMNAMEN1KMT2ACA2
SCHEMBL4064764 0.70 MAPT (0.48) SMN1; SMN2LMNAPOLBKMT2AKDM4E
SCHEMBL30996076 0.70 IFNAR1 (1.00) IFNAR1RECQLSMN1; SMN2LMNASLC6A4
Hydrochloric Acid SCHEMBL21964032 0.69 CA2 (0.60) SMN1; SMN2LMNAMEN1KMT2ACA2
Hydrochloric Acid SCHEMBL11635394 0.69 IFNAR1 (0.66) IFNAR1RECQLSMN1; SMN2LMNASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives H. LUNDBECK A/S (DK) 2009-07-30 — — US claimed
EP-1893596-A2 BENZOÝB¨FURANE AND BENZOÝB¨THIOPHENE DERIVATIVES H.Lundbeck A/S (DK) 2008-03-05 — — EP claimed
WO-2007023395-A2 BENZO[B]FURANE AND BENZO[B]THIOPHENE DERIVATIVES H. LUNDBECK A/S (US) 2007-03-01 — — WO claimed
US-20060287386-A1 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2006-12-21 — — US claimed
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives H. LUNDBECK A/S (DK) 2009-07-30 — — US disclosed
US-7534791-B2 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2009-05-19 — — US disclosed
EP-1893596-A2 BENZOÝB¨FURANE AND BENZOÝB¨THIOPHENE DERIVATIVES H.Lundbeck A/S (DK) 2008-03-05 — — EP disclosed
WO-2007023395-A2 BENZO[B]FURANE AND BENZO[B]THIOPHENE DERIVATIVES H. LUNDBECK A/S (US) 2007-03-01 — — WO disclosed
US-20060287386-A1 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2006-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287386-A1 Benzo[b]furane and benzo[b]thiophene derivatives CYP1B1, TBCB, CYP4B1 IFNAR1 2680/4885RECQL 1990/4885SMN1; SMN2 3237/4885
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives CYP1B1, TBCB, CYP4B1 IFNAR1 2680/4885RECQL 1990/4885SMN1; SMN2 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback